Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NBPF20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CLK4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
NBPF10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF639 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFATC2IP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBM39 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPCS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYSM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CALM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MALAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCNI - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM204A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMG1P5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITSN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on